Clinical trials referenced in this document:
Documents that mention this clinical trial
Funding for this research was provided by:
Grifols
Karolinska Institute
Article History
Received: 12 March 2022
Accepted: 23 June 2022
First Online: 18 July 2022
Declarations
:
: The Regional Ethics Committee of Linköping (Dnr 2017/478-31) approved this study. The Swedish Medical Products Agency also approved the protocol, which was registered prior to enrollment at EU Clinical Trials Register on September 22, 2017 (Eudra-CT 2017-003687-12). The volunteers consented to participate after having received oral and written information about the implications of the study. The study was conducted in compliance with the Declaration of Helsinki.
: Not applicable.
: R.G. Hahn holds a research grant from Grifols. Grifols played no role in the design, analysis, and interpretation of the data and in writing the manuscript. Remaining authors do not have any conflicts of interest.